Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
Read more
ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week.
The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients--recipients-- and those with sickle cell disease and diabetes.
"The adjusted prioritization described by the governor and agreed to by representatives from the major health systems in Maryland allow for those at higher risk for death per the CDC guidelines to receive this vaccine earlier," he said.
Health officials are estimating two million to three million shots are needed to immunize everyone that is already eligible to receive the vaccine-- meaning those including in Phase 1A, 1B and now 1C.
The state health department said the state is getting about 10,000 doses a day from the federal government.
For the latest information on coronavirus go to the Maryland Health Department's website or call 211. You can find all of WJZ's coverage on coronavirus in Maryland here.
We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.